Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 2
2018 4
2019 3
2020 6
2021 11
2022 15
2023 18
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review.
Brown LC, Bobo WV, Gall CA, Müller DJ, Bousman CA. Brown LC, et al. J Pers Med. 2023 Jun 30;13(7):1086. doi: 10.3390/jpm13071086. J Pers Med. 2023. PMID: 37511699 Free PMC article. Review.
This systematic review evaluated the animal and human evidence for pharmacomicrobiomics (PMx) interactions of antidepressant medications. Studies of gut microbiota effects on functional and behavioral effects of antidepressants in human and animal models were identified fr …
This systematic review evaluated the animal and human evidence for pharmacomicrobiomics (PMx) interactions of antidepressant medicati …
Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.
Jia L, Huang S, Sun B, Shang Y, Zhu C. Jia L, et al. Front Endocrinol (Lausanne). 2023 Mar 23;14:1149256. doi: 10.3389/fendo.2023.1149256. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37033254 Free PMC article. Review.
Although a set of measures including lifestyle intervention and antidiabetic drugs have been proposed to manage T2DM, problems associated with potential side-effects and drug resistance are still unresolved. Pharmacomicrobiomics is an emerging field that investigates the i …
Although a set of measures including lifestyle intervention and antidiabetic drugs have been proposed to manage T2DM, problems associated wi …
Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment.
Chen HQ, Gong JY, Xing K, Liu MZ, Ren H, Luo JQ. Chen HQ, et al. Front Med (Lausanne). 2022 Jan 19;8:742394. doi: 10.3389/fmed.2021.742394. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35127738 Free PMC article. Review.
However, for a considerable part of the population, these drugs still cannot significantly improve their symptoms. In order to explore the reasons behind, pharmacomicrobiomics provide unique insights into the drug treatment of hypertension by investigating the effect of bi …
However, for a considerable part of the population, these drugs still cannot significantly improve their symptoms. In order to explore the r …
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs - is it a new perspective for personalized treatment of cancer patients?
Kaźmierczak-Siedlecka K, Bulman N, Ulasiński P, Sobocki BK, Połom K, Marano L, Kalinowski L, Skonieczna-Żydecka K. Kaźmierczak-Siedlecka K, et al. Gut Microbes. 2023 Dec;15(2):2281017. doi: 10.1080/19490976.2023.2281017. Epub 2023 Nov 20. Gut Microbes. 2023. PMID: 37985748 Free PMC article. Review.
Intestinal bacteria are equipped with an enzyme apparatus that is involved in the active biotransformation of xenobiotics, including drugs. Pharmacomicrobiomics, a new area of pharmacology, analyses interactions between bacteria and xenobiotics. ...
Intestinal bacteria are equipped with an enzyme apparatus that is involved in the active biotransformation of xenobiotics, including drugs. …
Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism.
Dikeocha IJ, Al-Kabsi AM, Miftahussurur M, Alshawsh MA. Dikeocha IJ, et al. FASEB J. 2022 Jun;36(6):e22350. doi: 10.1096/fj.202101986R. FASEB J. 2022. PMID: 35579628 Review.
The gut microbiota is capable of biotransforming/metabolizing of various drugs and xenobiotic compounds as well as altering the activity and toxicity of these substances, thereby influencing how a host responds to drugs and xenobiotics and this emerging field is known as pharm …
The gut microbiota is capable of biotransforming/metabolizing of various drugs and xenobiotic compounds as well as altering the activity and …
Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
Conti G, D'Amico F, Fabbrini M, Brigidi P, Barone M, Turroni S. Conti G, et al. Genes (Basel). 2022 Dec 24;14(1):55. doi: 10.3390/genes14010055. Genes (Basel). 2022. PMID: 36672796 Free PMC article. Review.
Anticancer technologies that exploit tumor-associated bacteria to target tumors and biotransform drugs are also briefly discussed. In the field of pharmacomicrobiomics, multi-omics strategies coupled with machine and deep learning are urgently needed to bring to light the …
Anticancer technologies that exploit tumor-associated bacteria to target tumors and biotransform drugs are also briefly discussed. In the fi …
Interaction between drugs and the gut microbiome.
Weersma RK, Zhernakova A, Fu J. Weersma RK, et al. Gut. 2020 Aug;69(8):1510-1519. doi: 10.1136/gutjnl-2019-320204. Epub 2020 May 14. Gut. 2020. PMID: 32409589 Free PMC article. Review.
The interaction between gut microbes and commonly used non-antibiotic drugs is complex and bidirectional: gut microbiome composition can be influenced by drugs, but, vice versa, the gut microbiome can also influence an individual's response to a drug by enzymatically transforming …
The interaction between gut microbes and commonly used non-antibiotic drugs is complex and bidirectional: gut microbiome composition can be …
Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Sharma A, Buschmann MM, Gilbert JA. Sharma A, et al. Clin Pharmacol Ther. 2019 Aug;106(2):317-328. doi: 10.1002/cpt.1437. Epub 2019 May 7. Clin Pharmacol Ther. 2019. PMID: 30937887 Review.
The study of interactions between microbiome and pharmaceutical agents, i.e., pharmacomicrobiomics, has revealed an instrumental role of the microbiome in modulating drug response that alters the therapeutic outcomes. ...We also discuss the significance of studying diet-ge …
The study of interactions between microbiome and pharmaceutical agents, i.e., pharmacomicrobiomics, has revealed an instrumental role …
57 results